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Abstract
Carbon monoxide (CO) at low concentrations imparts protective effects in numerous preclinical small animal models of
brain injury. Evidence of protection in large animal models of cerebral injury, however, has not been tested. Neurologic
deficits following open heart surgery are likely related in part to ischemia reperfusion injury that occurs during
cardiopulmonary bypass surgery. Using a model of deep hypothermic circulatory arrest (DHCA) in piglets, we evaluated the
effects of CO to reduce cerebral injury. DHCA and cardiopulmonary bypass (CPB) induced significant alterations in metabolic
demands, including a decrease in the oxygen/glucose index (OGI), an increase in lactate/glucose index (LGI) and a rise in
cerebral blood pressure that ultimately resulted in increased cell death in the neocortex and hippocampus that was
completely abrogated in piglets preconditioned with a low, safe dose of CO. Moreover CO-treated animals maintained
normal, pre-CPB OGI and LGI and corresponding cerebral sinus pressures with no change in systemic hemodynamics or
metabolic intermediates. Collectively, our data demonstrate that inhaled CO may be beneficial in preventing cerebral injury
resulting from DHCA and offer important therapeutic options in newborns undergoing DHCA for open heart surgery.
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Introduction
Neurologic abnormalities occur in neonates undergoing cardio-
pulmonary bypass (CPB) and deep hypothermic circulatory arrest
(DHCA) for correction of congenital heart defects. Neuroprotec-
tive strategies have focused on perioperative management with
very few innovative options to reduce injury. Preconditioning as
a preoperative therapy to protect the brain prior to DHCA has not
been studied, but has otherwise been shown to be useful in other
clinical indications [1–7] such as organ transplantation to improve
function post transplant [8–13]. The preconditioning agent does
not have to be the same as the potentially lethal insult. In organ
transplantation, a brief ischemic time elicits a stress response,
which leads to altered metabolism, less inflammation, better tissue
perfusion and protective gene expression such as the anti-oxidants
and heat shock proteins [14–21].
Among a host of protective genes is heme oxygenase-1 (HO-1),
which is increased dramatically in response to stress and
importantly, when elevated, imparts potent salutary effects [22–
34]. Two isoforms of heme oxygenase exist and are principally
responsible for the catalysis of heme into bilirubin. During the
breakdown of heme, a molecule of carbon monoxide (CO),
biliverdin and iron are released. Biliverdin is rapidly converted to
bilirubin by biliverdin reductase while the iron is sequestered into
ferritin. The CO generated is exhaled unmodified. Recent efforts
have identified CO as the primary mechanism by which HO-1
imparts its beneficial effects in animals.
Inhaled CO is an important therapeutic option and has entered
clinical trials (www.clinicaltrials.gov). These include Carbon
Monoxide Therapy for Severe Pulmonary Arterial Hypertension,
Study of Inhaling Carbon Monoxide to Treat Patients with
Intestinal Paralysis after Colon Surgery, and Study of Inhaled
Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis. At low
concentrations (15 to 250 ppm), inhaled CO has beneficial effects,
mimicking those observed with HO-1 in animal models of
ischemia/reperfusion injury, organ transplantation, ileus, necro-
tizing enterocolitis and airway disease. More recently, Vieira and
colleagues showed that CO prevented neuronal apoptosis induced
by excitotoxicity and oxidative stress in a primary culture of mouse
cerebellar granule cells. [35] In a mouse model, Zeynalov and
colleagues evaluated the role of inhaled CO following 90-minutes
of transient focal brain ischemia. The authors found that
inhalation of 125 ppm or 250 ppm CO begun immediately at
the time of onset of reperfusion resulted in reduction in
hemispheric infarct volume, improved neurological deficit scores,
and limited brain edema. Inhalation of 250 ppm CO begun 1 to 3
hours after ischemia resulted in reduction of infarct volume and
improved neurological deficit scores. [36] Wang et al exposed
male wild-type and Nrf2-knockout mice to 250 ppm CO or air
control for 18 hours immediately after permanent middle cerebral
artery occlusion. CO neuroprotection was completely abolished in
Nrf2-knockout mice suggesting that the beneficial effect of inhaled
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pathway. [37].
However, the role of inhaled CO as a preconditioning
neuroprotective agent during DHCA has not been studied.
Neuroprotective studies by Mezrow et al suggest that disturbances
in cerebral blood flow and cerebral vascular resistance correlate
with clinical findings of neurologic injury after hypothermic
circulatory arrest and that cerebral metabolism is maintained by
increases in oxygen and glucose extraction, a relationship viewed
as potentially very important. [38,39] In order to define effects of
inhaled CO on neuroprotection during DHCA, this study
investigated differences in cerebral blood flow, cerebral hemody-
namics, cerebral metabolism, and cerebral pathology in piglets
preconditioned with inhaled CO before undergoing CPB and
DHCA.
Materials and Methods
Animals
The study was performed at the Animal Research Laboratory
Children’s Hospital Boston/Harvard Medical School in Boston
and approved by the Institutional Animal Care and Use
Committee (IACUC) at Children’s Hospital Boston. All animals
received humane care in compliance with the ‘‘Principles of
Laboratory Animal Care’’ formulated by the National Society for
Medical Research and the ‘‘Guide for the Care and Use of
Laboratory Animals’’ published by the National Institutes of
Health (NIH Publication No. 88-23, revised 1985).
Twelve Yorkshire female piglets (Parsons Farms, Providence
RI), 12 to 19 days old (mean 12.9 days) and weighing 2.2 kg to
4.7 kg (mean 3.4 kg ), were allowed to acclimate 2 days before
experimentation with food and water ad libitum. The piglets were
randomly assigned to Group I (no preconditioning before CPB/
DHCA –6 piglets) or Group II (preconditioned with CO the day
before CPB/DHCA –6 piglets).
The Group II animals were preconditioned with inhaled CO
(280 ppm CO/balance air – Airgas East, Cambridge MA) 1 day
prior to surgery. Piglets were placed in a closed chamber that
contained a CO monitoring device (T40 Rattler Single Gas
Monitor, Industrial Scientific Corporation, Oakdale PA). The CO
gas mixture was pumped into the chamber until a steady state CO
concentration of 250 ppm was reached. The piglets were exposed
continuously for 3 hours. For safety reasons, the chamber was then
flushed with 100% oxygen over 1 minute. The animals were
removed from the chamber and returned to their respective pens.
Identical exposures were done with controls except the pigs were
exposed to normal air.
Blood Sampling
Baseline blood samples (,1 cc) for all studies was drawn using
a blood gas syringe after insertion of the femoral artery catheter
and superior sagittal sinus catheter. Repeat samples were drawn
during cooling and rewarming on CPB, immediately after weaning
from CPB, every 30 minutes after weaning from CPB until death,
and when clinically indicated. Blood samples were immediately
analyzed for pH, oxygen, carbon dioxide, glucose, lactate,
hematocrit, sodium, and potassium using the blood gas analyzer.
Induction of Circulatory Arrest
On the day of surgery, piglets were premedicated with telazol
(6.6 mg/kg), xylazine (2.2 mg/kg), and atropine (0.04 mg/kg)
intramuscularly, intubated (non-cuffed 3.0 tube) and placed on
isoflourane and the animal’s depth of anesthesia was determined
by evaluating reflexes, muscle tone, and response of vital signs to
surgical stimulation. They were maintained on positive-pressure
ventilation (inspired oxygen greater than 40% and arterial carbon
dioxide tension 35 to 45 mm Hg). An intravenous catheter was
placed in an ear vein. A nasopharyngeal temperature probe was
placed in the esophagus. Femoral artery and femoral venous
catheters were placed for monitoring and blood drawing purposes.
The animals were placed on a cooling/warming blanket which
was initially used to surface cool the animals before DHCA and
later to rewarm the animals and to help maintain normal body
temperature after DHCA. Cefazolin (25 mg/kg) and methylpred-
nisolone (30 mg/kg) were given intravenously. Animals were
surface cooled and the head and groins were packed in ice.
A superior sagittal sinus (sss) cannulation was done prior to
cannulation for CPB. A midline scalp incision was made and
carried down to the periosteum. The periosteum was removed and
a 3 mm cutting burr was used to remove bone over the sinus using
3.5X magnification. A 24 gauge catheter was placed into the
sagittal sinus for cerebral venous blood sampling and monitoring
of cerebral venous pressure.
A Stockert double roller pump was used to generate non-
pulsatile pump flow at an initial rate of 100 ml/kg body weight in
all experiments. The oxygenator gas mixture consisted of 5%
carbon dioxide and 95% oxygen in all CPB groups. The CPB
bypass circuit consisted of the D 901 Lilliput 1 Newborn Hollow
Fiber Oxygenator with hardshell venous cardiotomy reservoir
(COBE Cardiovascular Inc., Arvada CO), Dideco D736 40
micron Arterial Line Filter (COBE Cardiovascular, Inc., Arvada
CO), Custom Smart Tubing Perfusion Pack (COBE Cardiovas-
cular Inc., Arvada CO), Terumo CDI 500 (Terumo Cardiovas-
cular Systems Corp., Tustin CA), and Hemocor HPH 400
(Minntech Corporation, Minneapolis MN). Venous drainage was
by gravity. The blood used for priming of the CPB circuit was
drawn on the morning of the experiment from an adult donor pig.
The CPB circuit was initially primed with Plasmalyte A, sodium
bicarbonate 7.4%, 2500 units heparin, and fresh heparinized
Yorkshire pig whole blood to achieve a hematocrit greater than or
equal to 30%.
Through a median sternotomy, the thymus was reflected
superiorly or excised and the pericardium opened. Two hundred
U/kg of heparin was given intravenously and the activated clotting
time maintained greater than 400 seconds until the piglet was
weaned from the circuit. A left atrial catheter for radioisotope
injection was positioned through the left atrial appendage into the
left atrium. The ascending aorta was cannulated with an 8F
Paediatric Arterial Cannula (Polystan A/S, Denmark) and the
right atrium was cannulated with a single 12F or 14F venous
cannula (Medtronic DLP, Minneapolis MN). A pulmonary artery
catheter for monitoring pulmonary artery pressure was placed.
CPB was initiated and the flow adjusted to maintain a perfusion
pressure of 40 to 50 mmHg. pH-stat strategy (natural alkaline shift
in response to the decreasing temperature is corrected by adding
carbon dioxide) was used during cooling below 32 degrees
Centigrade and for rewarming up to 32 degrees Centigrade
nasopharyngeal temperature. All animals were cooled using
surface cooling and the heater/cooler to a nasopharyngeal
temperature of 16 degrees Centigrade and then subjected to 100
minutes of circulatory arrest. Cardiac arrest was achieved after
placing a cross-clamp distal to the aortic cannula followed by
20 cc/kg of blood cardioplegia containing 1 part oxygenated
pump blood with 4 parts cardioplegia solution (1000 cc plasma-
lyte, 16.3 cc of 20% mannitol, 4.0 cc of 50% magnesium sulfate,
13.0 cc of 1 mEq/ml sodium bicarbonate, 13.0 cc of 1%
lidocaine, and 13.0 cc of 2 mEq/ml potassium chloride) which
was administered through a side port of the aortic cannula.
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the head and groins and whole body perfusion was reestablished
using the CPB circuit. The animals were rewarmed to a nasopha-
ryngeal temperature of 36 degrees centigrade using the heater/
cooler and the cooling/warming blanket. Weaning cardiac
support was provided with epinephrine (0.01 to 0.03 mg/kg/
minute) and was discontinued in all animals within the first 30
minutes. Weaning from bypass occurred approximately 34
minutes after the start of rewarming. Heparin was reversed with
2 mg/kg intravenous protamine. Animals were maintained on
isoflurane anesthesia until they were exsanguinated 6 hours after
the termination of CPB.
Piglets were reheparinized with 200 units/kg of heparin 2
minutes before exsanguination. Three liters of chilled normal
saline were infused at a pressure of 150 mm Hg through the side
port of the clamped aortic cannula followed by 3 liters of 10%
formalin. The piglets were decapitated and the head was placed in
chilled 10% formalin and refrigerated. Brains were removed in toto
no sooner than 1 week after death.
Measurements of Cerebral Blood Flow and Cerebral
Vascular Resistance
Cerebral blood flow (CBF) was measured with radionuclide-
labeled microspheres as originally described by Rudolph and
Heymann. [40] Approximately 0.5 to 1.5610
6 microspheres
1660.5 mm in diameter labeled with Ce141, Cr51, Ru103, Nb95
or Sc46 (PerkinElmer Life and Analytical Sciences, Billerica, MA)
were injected and flushed with 5 ml of saline into the left atrial
catheter i.) before CPB, ii.) immediately after weaning from CPB,
iii.) 1 hour after weaning from CPB, iv.) 3 hours after weaning
from CPB, and v.) 6 hours after weaning from CPB. Samples of
blood were taken from the femoral artery line at a constant rate
(2.00 ml/min) with a Harvard withdrawal pump beginning 15
seconds before injection of microspheres and ending 75 seconds
after injection.
Blood Flow Determination
Fixed brains were bisected in the sagittal plane. Tissue blocks
from the left hemisphere were cut to encompass brain regions
known for their vulnerability to hypoxia/ischemia. Two specimens
were taken from 3 areas of the fixed brain of each animal: frontal
neocortex, striatum, and hippocampus. Analyses of these samples
to determine blood flow were carried out by computer solution of
multiple simultaneous linear equations (Compusphere, Packard
instruments). Blood flow was calculated using the following
equation: Cerebral blood flow (ml/100 g/min)=(cerebral tissue
counts6rate of withdrawal)6100/(counts in reference sample6
weight of brain sample). Cerebral vascular resistance (CVR) was
calculated using the equation: CVR (mm Hg/ml/100 g/min) =
[MAP – MSSSP (mm Hg)]/CBF (ml/100 gm/min) where MAP is
mean arterial pressure and MSSSP is mean superior sagittal sinus
pressure.
Assessment of Cell Death
Damaged neurons (DN) included nuclear pyknosis with
wrinkled nuclear outlines and minimal cytoplasmic change,
nuclear pyknosis with eosinophilic cytoplasm, ghost neurons, or
apoptotic bodies. Counts were scored as follows: 1, 0 to 5 DN seen
per high-power field; 2, 6 to 15 DN seen per high-power field; 3,
16 to 25 DN seen per high-power field; and 4, greater than 25 DN
seen per high-power field. Twenty randomly selected 4006fields
of H&E stained frontal neocortex, striatum, and hippocampus
were examined for each animal by bright-field microscopy. Counts
for each area were averaged for a final score.
Serum Measurements
Blood samples from the femoral artery and superior sagittal
sinus were obtained simultaneously for calculation of cerebral
oxygen extraction (arteriovenous difference in content of oxygen),
cerebral glucose extraction (arteriovenous difference in glucose),
cerebral lactate extraction (arteriovenous difference in lactate),
oxygen/glucose index (OGI), and lactate/glucose index (LGI).
TUNEL Staining and Quantitation
Tissue sections from the right frontal neocortex/striatum and
hippocampuswerecutfromparaffinblocksatathicknessof5 mmand
mounted. Sections were stained by terminal nick-end labeling of
cleaved DNA with fluorescein-conjugated nucleotides (ApopTag
FluoresceinInSituApoptosisDetectionKit;ChemiconInternation-
al,Billerica,Massachusetts).Thesectionswerealsostainedfornuclei
(DAPI;MolecularProbes,Eugene,Oregon).TUNEL-positiveand–
negative nuclei were counted using Metamorph software (Version
6.2; Molecular Devices, Downingtown, Pennsylvania) on 5 to 10
random frontal neocortex/striatum and hippocampus fields per
section,readatlowmagnification.Resultsareexpressedasapoptotic
nuclei (AN) per 1,000 total nuclei.
Caspase-3 Immunohistochemistry
Formalin-fixed, paraffin-embedded brain tissue sections of
hippocampus were deparaffinized with xylene, rehydrated grad-
ually with graded alcohol solutions (100%, 95%, and 80%), and
then washed with deionized water. For antigen unmasking,
sections were treated in trypsin solution for 10 minutes at 37uC.
Sections were then washed with deionized water and incubated
with 3% H2O2 for 5 minutes. Sections were then incubated with
a 1:300 dilution of the rabbit polyclonal anti-active caspase-3
(Promega, Madison, WI) overnight at 4uC. After three PBS
washes, sections were incubated with the secondary antibody,
a biotinylated goat anti-rabbit IgG, at 37uC for 30 minutes, and
with peroxidase-conjugated strepavidin-biotin complex (Santa
Cruz Biotechnology, Santa Cruz, CA) at 37uC for 30 minutes.
Diaminobenzidine (DAB) substrate (Zymed, South San Francisco,
CA) was applied as the chromogen, giving a brown reaction
product, and the sections were counterstained with Mayer’s
hematoxylin.
Statistical Analysis
The Kolmogorov-Smirnov goodness-of-fit test was used to
assess for normality of the data and no gross departures were
detected. Therefore, baseline values were compared by one-way
analysis of variance (ANOVA) with means and standard deviations
reported. Mean differences between the treatment groups at
various time points were assessed using two-way repeated-
measures ANOVA (group and time as factors) with a mixed-
model approach and a compound symmetry covariance structure
to account for the within-animal correlation. [41] The Green-
house-Geisser F-test for small samples was chosen for assessing
significance group and time effects. [42] TUNEL results were
compared between the two groups using a Poisson regression
model for analyzing count data. Analysis of the data was
performed with use of the PROC MIXED and GEE procedures
in the SPSS software package (version 16.0, SPSS Inc./IBM,
Chicago, IL). Two-tailed values of P,.05 were regarded as
statistically significant.
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Hemodynamic and Hematologic Parameters Remained
Stable Throughout CPB
Preoperative data (age and weight) were similar. Cooling and
rewarming times during CPB were similar. There were no
statistically significant differences at baseline between the groups
regarding temperature, mean arterial pressure, arterial blood
gases, sss blood gases, sss saturation values, oxygen extraction
ratio, hematocrit values, arterial glucose values, and arterial
lactate values, which were compared using 2-way repeated-
measures ANOVA. (Table 1) No significant differences
between the 2 groups were found for any of these variables
throughout the time period from baseline to 6 hours after
weaning from CPB.
Effects of Inhaled CO on Systemic and Cerebral
Hemodynamics
Mean pulmonary artery pressure (MPAP) and mean superior
sagittal sinus pressure (MSSSP) were higher in CO precondi-
tioned animals at all time points (Figure 1). Statistical
significance was observed for MPAP immediately after CPB
and for MSSSP 6 hours after CPB. Although cerebral perfusion
pressure (MAP – MSSSP) was slightly higher in the control
group during the study, this difference did not reach statistical
significance. Cerebral blood flow (CBF) was similar in both air
and CO-treated piglets at all time points (Figure 2). Immedi-
ately after weaning from CPB, CBF increased markedly from
baseline and then decreased to below baseline at 1 hour and 3
hours after weaning from CPB. Six hours after weaning from
CPB, CBF was higher than baseline in all groups and was
similar in air and CO-treated piglets.
Cerebral vascular resistance (CVR) was elevated over baseline
in both groups 1 hour and 3 hours after weaning from CPB and
then dropped below baseline 6 hours after weaning. This was
expected based on CBF (Figure 2). CVR immediately after
weaning did not change significantly from baseline with no
statistical difference between air or CO-treated animals.
Given the reports that CO can impart vasodilatory effects, we
expected that cerebral perfusion pressures and CBF would be
higher and that CVR would be lower than what was observed
in the air treated animals. These results suggest that
preconditioning with CO was ineffective at modulating cerebral
vasodilation and improved cerebral blood flow immediately
before or after CPB.
CO Influences Metabolism in the Brain Following CPB
Differences between arteriovenous oxygen tension (A-VDO2)
were greater than differences between arteriovenous glucose (A-
VDGLUCOSE) at baseline. No significant differences between A-
VDO2 and A-VDGLUCOSE values between air and CO-treated
animals were observed. (Figure 3).
The oxygen/glucose index (OGI) describes the relationship
between A-VDO2 and A-VDGLUCOSE and is independent of
cerebral blood flow. Stoichiometrically, 6 moles of oxygen are
required to metabolize 1 mole of glucose. If all glucose is oxidized
and no other substrate is consumed, A-VDO2/A-VDGLUCOSE is
equal to 6. The ratio is less than 6 if all the glucose extracted is not
oxidized and greater than 6 if other substrates (i.e. lactate,
pyruvate, acetoacetate, b-hydroxybutyrate, glutamate) are used as
a source of carbon. The equation for OGI defines this biochemical
relationship:
OGI(%)~(arteriovenous oxygen difference½mmol=ml )=
(arteriovenous glucose difference ½mmol=ml 
|6)|100:
If all of the glucose extracted is oxidized and no other substrate
is consumed, OGI(%) is 100%. Values less than 100% indicate
that not all of the glucose extracted is oxidized (anaerobic
metabolism) and values greater than 100% indicate that other
substrates are used as a source of carbon.
Prebypass mean OGI (%) was comparable in both groups and
determined to be 63% (642) in the control group and 63% (647)
in the CO group. The OGI was higher in the CO-treated animals
at all other time points (p=0.006; Figure 4, * indicates
statistical significance).
In the control group the OGI decreased with CPB and cooling.
This is attributed to a reduction in A-VDO2 to a greater extent
than the reduction in A-VDGLUCOSE (Figure 3). During
rewarming, the OGI returned to baseline immediately after
weaning from CPB. OGI then decreased to below baseline values
for the duration of the study. (Figure 4).
In the CO-treated group, the OGI increased over baseline in
the presence of CPB and cooling. (Figure 4) A-VDO2, superior
sagittal sinus saturation and oxygen extraction ratios were in close
agreement between the groups, but A-VDGLUCOSE was lower in
the CO group before, during and immediately after CPB
(Figure 3) suggesting that glucose was being metabolized at
a lower rate in the CO-treated animals. Both A-VDO2 and A-
VDGLUCOSE returned to baseline by the end of the study. The
calculated OGI, likewise, returned to baseline.
A negative A-VDLACTATE is consistent with lactate being
produced in the brain. Assessment of A-VDLACTATE levels trended
toward being more negative in the control group basally, but did
not achieve statistical significance (Figure 5). During cooling on
CPB, A-VDLACTATE levels were similar. While A-VDLACTATE
was negative in air and CO-treated animals during cooling, A-
VDLACTATE became positive in the control group and remained
negative in CO-treated animals during rewarming on CPB. After
weaning from CPB, however, A-VDLACTATE became negative in
controls and remained low in contrast to CO-treated animals
which recovered and were positive after CPB at 1 and 3 hr (1 hr
post CPB: air at 20.02 mml/ml versus CO at +0.03 mmol/ml,
p,0.05; 3 hr post CPB: air at 20.01 mmol/ml versus CO at
+0.04 mmol/ml, p,0.05) at which point the A-VDLACTATE in
both groups became positive (Figure 5, * indicates statistical
significance).
The lactate/glucose index (LGI) is a quantitative expression
describing the amount of glucose consumption that appears as
lactate production. If all extracted glucose is metabolized to
lactate, A-VDLACTATE/A-VDGLUCOSE is equal to the absolute
value 2. The equation for LGI defines this biochemical relation-
ship:
LGI(%)~(arteriovenous lactate difference½mmol=ml )=
(arteriovenous glucosedifference ½mmol=ml 
|2)|100:
If all of the extracted glucose is metabolized to lactate the LGI
(%) is 100%. A negative LGI results if glucose is metabolized to
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suggests that lactate is further metabolized by the cell and tissue.
The LGI basally before surgery were 0.03 and 20.25 for the
control and CO-treated animals respectively with both air and CO
being negative during cooling with no statistical difference between
groupsobserved.TheLGIbecamepositiveincontrolanimals(1.25)
duringrewarmingonCPBsuggestingthatlactatewasmetabolizedby
the brain during this time (Figure 5, * indicates statistical
significance). The LGI in the CO-treated animals was negative
(24.80) during rewarming, but became positive in CO-treated
animals immediately after weaning from CPB (0.69) Differences
between air treated and CO-treated groups reached statistical
significance1hourpostCPB(airtreatedgroup0.15andCO-treated
group2.50,p,0.05)and3hourspostCPB(airtreatedgroup20.48
and CO-treated group 1.92, p,0.05).
Taken together these data suggest that CO induces a metabolic
change in the brain of piglets undergoing CPB/DHCA. OGI was
higherinCO-treatedanimalsexceptatbaselineandwasstatistically
significantduringcoolingand warmingonCPBandat3hoursafter
weaning from CPB. One hour after weaning from CPB, LGI
Table 1. Hemodynamic and Hematologic Parameters.
PRE CPB AFTER CPB 1 HR AFTER CPB 3 HRS AFTER CPB 6 HRS AFTER CPB
TEMP
CONTROL 32.4+/21.6 34.6+/21.4 32.3+/22.0 34.2+/21.1 35.9+/21.3
CO-TREATED 33.0+/22.1 34.0+/22.6 33.1+/21.8 35.9+/21.8 36.2+/21.2
MAP (mm Hg)
CONTROL 55+/210 74+/214 66+/266 5 +/286 0 +/210
CO-TREATED 54+/287 1 +/213 62+/265 9 +/245 8 +/24
pHa
CONTROL 7.49+/20.10 7.36+/20.11 7.43+/20.04 7.45+/20.06 7.43+/20.06
CO-TREATED 7.50+/20.06 7.40+/20.06 7.40+/20.04 7.44+/20.06 7.42+/20.08
PaO2 (mm Hg)
CONTROL 619+/267 314+/2184 451+/2199 444+/2142 441+/2171
CO-TREATED 600+/2106 372+/2279 463+/2162 419+/2142 480+/2183
PaCO2 (mm Hg)
CONTROL 37.7+/29.7 46.3+/213.9 40.2+/24.1 41.9+/24.8 43.5+/23.3
CO-TREATED 34.6+/28.5 38.3+/210.7 40.1+/24.8 39.1+/20.9 42.1+/25.0
pHsss
CONTROL 7.42+/20.08 7.30+/20.10 7.34+/20.01 7.38+/20.04 7.35+/20.06
CO-TREATED 7.43+/20.05 7.36+/20.03 7.31+/20.05 7.35+/20.06 7.38+/20.03
PsssO2 (mm Hg)
CONTROL 44.1+/211.8 50.6+/210.5 37.9+/26.6 46.3+/28.8 47.4+/215.8
CO-TREATED 45.3+/213.4 43.4+/218.6 44.3+/29.9 39.3+/29.9 43.4+/212.2
PsssCO2 (mm Hg)
CONTROL 48.2+/212.4 56.6+/213.6 60.0+/29.8 55.7+/26.1 58.4+/26.5
CO-TREATED 46.9+/25.4 47.4+/27.2 55.5+/26.7 57.2+/26.7 53.3+/25.2
sss Saturation (%)
CONTROL 60+/210 64+/214 50+/212 59+/212 60+/222
CO-TREATED 69+/219 61+/227 56+/213 51+/214 60+/215
OER
CONTROL 70+/265 3 +/211 66+/218 62+/214 63+/216
CO-TREATED 63+/210 58+/218 65+/210 66+/214 67+/211
HEMATOCRIT
CONTROL 35.2+/24.5 36.7+/25.8 34.7+/25.6 35.3+/28.1 34.2+/27.6
CO-TREATED 37.3+/28.3 38.2+/24.3 35.7+/22.4 37.8+/25.0 33.0+/24.2
Arterial Glucose
CONTROL 161+/258 138+/236 142+/251 181+/253 201+/258
CO-TREATED 143+/2122 136+/281 173+/278 174+/283 184+/257
Arterial Lactate
CONTROL 4.0+/22.8 9.9+/24.3 7.4+/21.7 5.2+/21.7 4.6+/23.9
CO-TREATED 3.5+/21.3 8.2+/21.3 7.5+/20.9 5.7+/21.8 5.4+/21.7
doi:10.1371/journal.pone.0041982.t001
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significant at 1 hourand 3 hoursafter weaning from bypass.
CO Abrogated Apoptosis of Neurons
Cellular damage in the frontal neocortex, striatum, and
hippocampus was determined by TUNEL staining. Cell death
likely comprised a combination of necrosis and apoptosis in both
groups (Figure 6). TUNEL staining showed a significant increase
in positive apoptotic counts in the neocortex/striatum versus naı ¨ve
which was abrogated in CO-treated piglets versus controls (0.5/
1000 cells versus 21.6/1000 cells), but did not achieve significance
in this cohort. In the hippocampus, however, there was a greater
number of TUNEL positive cells in the air-treated animals which
was significantly reduced counts in CO-preconditioned piglets
(4.4/1000 cells versus 1.1/1000 cells respectively, p,0.03).
Caspase-3 staining of the hippocampus showed a greater number
of caspase-3 positive staining, indicative of cell death in air-treated
animals undergoing –CPB and DHCA. In contrast, animals
treated with CO and then subjected to CPB and DHCA showed
a marked reduction in caspase-3 positive staining in the
hippocampus (Figure 6) thereby indicating that CO offers
salutary effects in limiting cell death in the brain in piglets
undergoing CPB and DHCA.
Discussion
The data presented here continue to support the concept that
low concentrations of inhaled CO are beneficial in models of
ischemic injury. A clinically relevant CO preconditioning regimen
imparted potent cerebroprotection evidenced by less cell death in
the cortex and hippocampus in response to CPB and DHCA.
While the exact molecular target remains unknown, there is clearly
an effect of CO that results in altered bioenergetics and
metabolism in the brain.
Cerebroprotective effects have been well-described with HO-1
induction. [43–45] The protective effects of HO-1 induction, and
therein the endogenous generation of CO, can be mimicked in
nearly all instances using inhaled CO or administration of carbon
monoxide releasing molecules (CO-RMs). [46] Activation of HO-
1 or administration of CO has been shown to regulate a number of
specific cell signaling pathways including MAP kinases, BKCa
channels, guanylyl cyclase, PPARc, and HIF1a. [47] Modulation
of these pathways is highly dependent on when CO is
administered, either pre or post stressor. Paradoxically, CO
increases ROS generation when administered as a pretreatment
primarily through binding to mitochondrial oxidase complexes.
The transient ROS generation leads to preconditioning of the cell
towards an anti-inflammatory and anti-apoptotic phenotype via
upregulating cytoprotective molecules including HO-1.
Our study suggests that a change in metabolic substrate
modulation may be key in neuroprotection. Functions of the
central nervous system are mainly excitation and conduction,
electrical energy being derived from chemical processes. Stoichio-
metric modeling of brain metabolism in response to tissue hypoxia
involves central metabolism (glycolysis, pentose phosphate path-
way, TCA cyle), lipid metabolism, reactive oxygen species
detoxification, amino acid metabolism, the glutamate-glutamine
cycle and neurotransmitter metabolism. [48] There has been
continued debate as to the primary fuel of brain cells during basal
and stressed conditions. [49] Lactate may be the preferred energy
substrate of activated neurons. Our findings are consistent with
a change to lactate as the metabolic substrate for neurons in
a piglet model of DHCA/CPB. A-VDLACTATE and LGI became
positive and statistically significant at 1 and 3 hours after weaning
from CPB. Changes in bioenergetics in response to CO may
Figure 1. Mean pulmonary artery pressure (MPAP) and mean superior sagittal sinus pressure (MSSSP) were higher in the CO
preconditioned piglets at all time points. Data represent the means 6 SD of 6 animals/group, MPAP p,0.05 immediately after CPB and MSSSP
p,0.05 6 hours after CPB.
doi:10.1371/journal.pone.0041982.g001
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this would corroborate the fact that CO targets the mitochondrial
hemoproteins to modulate ATP generation and O2 consumption;
however this was performed in isolated mitochondria and not
whole cell preparations or tissues. CO also activates guanylate
cyclase to increase cGMP levels in neurons and subsequent
opening of mitochondrial K channels, critical for CO inhibition of
apoptosis. [35] Queiroga and colleagues studied the ability of CO
Figure 2. (CBF). Data represent the means 6 SD of 6 animals/group. Cerebral blood flow (CBF) was similar in air and CO-treated piglets at all
time points. After weaning from CPB, CBF increased from baseline and then decreased to below baseline at 1 and 3 hours after weaning. At 6 hours
after weaning, CBF was above baseline. There were no statistical differences between the Air and CO groups. 2 (CVR). Data represent the means 6
SD of 6 animals/group. Cerebral vascular resistance (CVR) reflected changes seen with CBF and were similar in air and CO-treated piglets at all time
points. CVR was higher than baseline in both groups 1 hour and 3 hours after weaning from CPB and below baseline 6 hours after weaning. There
were no statistical differences between the Air and CO groups.
doi:10.1371/journal.pone.0041982.g002
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PLoS ONE | www.plosone.org 7 August 2012 | Volume 7 | Issue 8 | e41982Figure 3. Arteriovenous difference in oxygen tension (A-VDO2) was greater than arteriovenous difference in glucose (A-VDGLUCOSE)
except during cooling when A-VDGLUCOSE of the control animals was greater than A-VDO2. A-VDO2 in the CO-treated group was higher at
3 and 6 hours after CPB. A-VDGLUCOSE was higher in the air group at baseline, during cooling and rewarming on CPB and immediately after CPB. While
there were trends in A-VDO2 and A-VDGLUCOSE values between air and CO-treated animals, no significant differences were observed. Data represent
the means 6 SD of 6 animals/group.
doi:10.1371/journal.pone.0041982.g003
Figure 4. OGI(%) was similar at baseline in both groups, but was above baseline in the CO-treated group thereafter. In the air group,
OGI(%) was below baseline at all time points. Data represent the means 6 SD of 6 animals/group, p=0.006 repeated measure ANOVA. * indicates
statistical significance.
doi:10.1371/journal.pone.0041982.g004
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PLoS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e41982Figure 5. (A-VDLACTATE). In the air group, A-VDLACTATE was more negative at baseline than the CO-treated group, became positive
during warming on CPB, and was negative immediately after weaning from CPB, 1 hour after CPB, and 3 hours after CPB. In contrast,
A-VDLACTATE was negative during CPB and become positive after weaning from CPB. At 6 hours after CPB, A-VDLACTATE was positive in both groups.
Data represent the means 6 SD of 6 animals/group, p,0.05 at 1 hour after CPB and 3 hours after CPB. * indicates statistical significance. 5 (LGI%).
LGI% was similar at baseline and negative in both groups during cooling on CPB. In the air group, LGI% became positive during warming on CPB.
LGI% was negative in the CO_treated animals during warming on CPB but was positive thereafter. Data represent the means 6 SD of 6 animals/
group, p,0.05 at 1 hour after CPB and 3 hours after CPB. * indicates statistical significance.
doi:10.1371/journal.pone.0041982.g005
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antiapoptotic effects of CO is due to the inhibition of mitochon-
drial membrane permeabilization, a major factor in the intrinsic
apoptotic pathway. [50] Precisely how metabolism of lactate
relates to the changes observed in mitochondria and subsequent
cerebral cytoprotection will help to further define the role of this
Figure 6. (TUNEL). Quantitation of TUNEL staining in indicated brain sections from neonatal piglet after CPB 6 CO showed more
apoptosis in the control group versus CO in the hippocampus and trending sections from the neocortex and striatum. Data represent
mean 6 SD of 6 animals/group, *p,0.03. Untreated pigs showed ,0.1 positively stained cell/field of view (FOV). (Caspase-3). Representative tissue
sections stained for activated Caspase-3 in the hippocampus from neonatal piglets after CPB 6 CO. Note the intense positive brown staining
indicating activated caspase-3 localized to the hippocampus in the control, air-treated pigs versus nearly no positive staining in the CO treated pigs.
Images are representative of n=6–8/group.
doi:10.1371/journal.pone.0041982.g006
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lowering cellular dependency on oxidative phosphorylation, even
transiently, would lead to reduced ROS and be reflected as
abrogated cell death.
CO also acts to influence vasomotor tone, albeit rather small
potency when compared to nitric oxide, but has been shown
regulates cerebral vasodilation. [51] Exogenous administration of
CO dilates pial arteries of baby and juvenile pigs acting as an
autocrine/paracrine messenger in the regulation of cerebrovascu-
lar hemodynamics and can prevent epileptic seizures in newborn
piglets with no loss of cerebrovascular reactivity 2 days after
administration of CO. Zimmermann et al concluded that pre-
treatment of the piglets elicits vasodilator properties on the
cerebral circulation protecting the brain from cerebrovascular
injury caused by seizures. [52] Immediately following DHCA, an
elevated intracranial pressure (ICP) may result in reduction of
cerebral blood flow and it is speculated that neurophysiological
recovery and behavior are impaired in animals with a higher ICP
and that suppression of cerebral metabolism is associated with
a lower ICP. [53] Daley and colleagues showed that this
preconditioning effect results in increased ICP caused by cerebral
vasodilation in the piglet model. [54] In hypoxia/ischemia injury
seen with DHCA, elevation of ICP is associated with brain
pathology [55,56]. In our study, superior sagittal sinus saturation
and superior sagittal sinus oxygen content were similar in Groups I
and II (air vs CO respectively). Cerebral perfusion pressures and
CBF and CVR in the neocortex, striatum, and hippocampus were
also similar between treatment groups. CO-treated animals
exhibited higher MSSSP with less apoptosis which did not
correlate with decreased oxygen delivery, changes in CBF or
neuropathology. Mean pulmonary artery pressures (MPAP) were
higher in the CO-treated group and statistically significant
immediately after CPB. The higher MPAP seen in the CO-
treated animals may explain the elevated MSSSP observed in the
CO treated animals; however, cerebral perfusion pressures and
CBF and CVR in the neocortex, striatum, and hippocampus were
similar between treatment groups. These results suggest that
preconditioning with CO modulates cerebral injury following
a prolonged period of DHCA despite an increase in MSSSP and
might improve cerebral outcome after a prolonged period of
DHCA despite an increased MSSSP. The observed cerebropro-
tective effects may result from changes in cerebral metabolism or
modulation of inflammation and apoptosis which is the focus of
future experiments [57]. Additionally, in a pig model of kidney
transplant and ischemic-reperfusion injury, CO was also protective
when administered intraoperatively [58]. CO treatment of
recipients only led to increased repair of the damaged kidney
through induction of proliferative genes. This is unlikely the mode
of action of CO here since CO was administered as a pretreatment,
but remains to be explored. More likely is that the preconditioning
results in a state of tolerance to the subsequent stress.
Cerebral metabolism with DHCA is highly complex and
incompletely understood. Metabolic compartmentalization in the
intact brain reflects metabolic alterations between different
neuronal components and even among different neuronal
populations. Under normal physiological conditions, glucose is
the primary source of fuel for the brain. The distribution of energy
substrates from the systemic circulation into neurons is principally
determined by astrocytes and the dependence of cerebral function
on blood glucose as a fuel does not exclude lactate or other
substrates as an energy source. The concept of ‘‘coupling’’ of
oxidative metabolism and functional activity in the brain has,
however, been challenged. A greater increase in CBF and
CMRGLUCOSE with little change in CMRO2 during stimulation
suggest increased lactate production as active neurons release large
amounts of lactate [59–61]. In a seizure model in rats, Schridde et
al showed that increases in hemodynamic, metabolic, and
neuronal activity are dependent on the interaction between
hemodynamics and metabolism. [62].
During hypoxia and ischemia, astrocytes provide both structural
and metabolic support and exhibit a high glycolytic rate
generating primarily lactate. Vega and colleagues concluded that
there is a shift in the metabolic response to energy conservation
and a change in cerebral metabolism [63]. Bouzier and colleagues
showed that
13C-labeled lactate was a major substrate for oxidative
metabolism in C6 glioma cells and hypoxic conditions were found
to lead to the accumulation of lactate as a rich energy source. [64]
In a study in newborn piglets with intrauterine growth restriction,
Moxon-Lester et al concluded that increased cerebral lactate is
neuroprotective. [65] In our study, A-VDO2 and A-VDGLUCOSE
showed no differences between air- and CO-treated animals, but
statistically significant differences in OGI (statistically significant
during cooling and warming and 3 hours after weaning from
CPB), A-VDLACTATE (statististically significant 1 hour and 3 hours
after weaning from CPB), and LGI (statistically significant 1 hour
and 3 hours after weaning from CPB) between groups. The
change in glucose and lactate metabolism in the brains of piglets
preconditioned with CO undergoing CPB/DHCA showed less
lactate production and/or higher lactate consumption. Figure 4
suggests that CO increases oxidative metabolism which would
result in less lactate production. However, higher lactate
consumption by neurons induced by CO as an alternative source
of carbon cannot be overlooked.
Schurr et al and Occhipinti et al studied the role of lactate
during glycolysis and hypothesized that lactate is the primary
energy substrate for neurons under aerobic conditions and that
interference with neuronal lactate utilization could result in
damage [66,67]. Gordon et al showed that the ability of astrocytes
to induce vasodilation relies on the metabolic state of rat brain
tissue and that lactate attenuates transporter-mediated uptake of
prostaglandin E2 resulting in vasodilation, a preconditioning effect
[68]. Won and colleagues have investigated whether intraperito-
neal injection of lactate after hypoglycemia reduced neuronal
death. Lactate administration with glucose supplementation
reduced neuronal death by 80% in the hippocampus and reduced
superoxide production and microglia activation. The authors
hypothesize that increasing brain lactate following hypoglycemia
offsets the decrease in NAD(+). This was found to be due to
overactivation of PARP-1 acting as an alternative energy substrate
that bypassed glycolysis and be fed directly to the citric acid cycle
to maintain cellular ATP levels. [69] In our study, A-VDLACTATE
and LGI became positive in both groups, but was more striking in
the CO preconditioned piglets. This suggests a change in cerebral
metabolism of lactate related to CO preconditioning prior to
DHCA that may be important in neuroprotection.
In summary, preconditioning of the neonatal piglet with inhaled
CO prior to CPB/DHCA did not result in differences in CBF and
CVR between groups. MSSSP was increased in the precondi-
tioned animals, but A-VDO2 was not changed. There were
significant differences in glucose and lactate metabolism between
the groups and corresponding histopathology clearly showed that
apoptosis was significantly less in the CO-treated animals. These
results suggest that preconditioning with CO results in a change in
cerebral metabolism of glucose and lactate that corresponds with
neuroprotection. Whether the change in tissue bioenergetics is
a direct effect of CO or indirectly through improved tissue
protection remains to be determined. With CO currently in
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undergoing CPB may be imminent.
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